The Union health ministry has approved the shorter, less toxic, and more effective treatment regimen — BPaLM— against the multi-drug-resistant tuberculosis under its National TB Elimination Program. “While traditional MDR-TB treatments can last up to 20 months with severe side effects, BPaLM regimen can cure the drug-resistant TB in just six months with high treatment success rate,” the health ministry …
Optimism is the madness of insisting that all is well when we are miserable. The latest WHO Global TB Report reveals that India has the world’s largest TB epidemic; at 2.6 million, the country accounts for the highest number of TB cases as well as multi-drug resistant cases. A study from Mumbai highlighted an unacceptably long average delay between a …
April 10, 2024 12:15 am | Updated 01:30 pm IST With less than two years left to achieve the ambitious goal set by Prime Minister Narendra Modi in 2018 to “eliminate” TB in India, the pharmacy of the Global South is once again struggling to treat patients with drug-sensitive TB. Just seven months ago, there was an acute shortage of …
Tuberculosis is a treatable disease, but drug resistance is now a major public health concern exacerbated by the emergence of multi and extensively drug-resistant TB. If long treatment, higher drug toxicity, and costly drug treatment make the MDR and extensively drug-resistant TB challenging to treat, a group of scientists led by CSIR-Centre for Cellular & Molecular Biology director Vinay Kumar …
Mumbai On the eve of World Tuberculosis Day, a report from the Brihanmumbai Municipal Corporation revealed that Mumbai recorded more tuberculosis deaths in 2021 than the previous three years. Collated for four years, the civic body’s data shows that Mumbai registered 1,917 TB deaths last year as against 1,352 in 2020, 1,478 in 2019 and 1,471 in 2018. However, BMC …